BRIEF published on 06/03/2025 at 17:05, 1 year 2 months ago Points forts de l'assemblée générale annuelle 2025 d'Evotec SE Décisions Des Actionnaires Perspectives Stratégiques Découverte De Médicaments Assemblée Générale Annuelle D'Evotec 2025 Présentations Du Conseil D'administration
BRIEF published on 06/03/2025 at 17:05, 1 year 2 months ago Evotec SE Annual General Meeting 2025 Highlights Drug Discovery Shareholder Decisions Strategic Outlook Evotec 2025 AGM Board Introductions
PRESS RELEASE published on 06/03/2025 at 17:00, 1 year 2 months ago Evotec SE: Results of the Annual General Meeting 2025 Evotec SE shareholders approve proposals at Annual General Meeting 2025, featuring strategic outlook and new Management Board members; 46.45% share capital represented Annual General Meeting Shareholders Evotec SE Management Board Strategic Outlook
BRIEF published on 05/07/2025 at 07:35, 1 year 3 months ago Evotec obtient une subvention de 2,5 millions de dollars pour le développement d'un traitement contre la tuberculose Evotec Santé Mondiale Résistance Aux Médicaments Tuberculose Fondation Gates
BRIEF published on 05/07/2025 at 07:35, 1 year 3 months ago Evotec Secures $2.5 Million Grant for Tuberculosis Treatment Development Evotec Global Health Drug Resistance Tuberculosis Gates Foundation
PRESS RELEASE published on 05/07/2025 at 07:30, 1 year 3 months ago Evotec receives $ 2.5 m grant to generate next generation tuberculosis treatments Evotec SE receives $2.5 m grant from Gates Foundation to develop next-generation tuberculosis treatments, focusing on drug combinations to reduce treatment duration and overcome resistance Evotec SE Grant Gates Foundation Tuberculosis Treatments Drug Combinations
BRIEF published on 05/06/2025 at 07:05, 1 year 3 months ago Evotec SE publie ses résultats financiers du premier trimestre 2025 dans un contexte de marché faible Partenariats Stratégiques Perspectives Financières Croissance Des Produits Biologiques Evotec T1 2025 Dégradation Des Protéines
BRIEF published on 05/06/2025 at 07:05, 1 year 3 months ago Evotec SE Reports Q1 2025 Financial Results Amid Soft Market Strategic Partnerships Financial Outlook Biologics Growth Protein Degradation Evotec Q1 2025
PRESS RELEASE published on 05/06/2025 at 07:00, 1 year 3 months ago Evotec SE reports Q1 2025 results: Paving the way for 2025 growth in soft market environment Evotec SE reports Q1 2025 results, highlighting strategic partnerships & sustainable growth plans in soft market. 2025 guidance and 2028 outlook confirmed Strategic Partnerships Evotec SE Growth Plans Q1 2025 Soft Market
BRIEF published on 04/29/2025 at 10:07, 1 year 3 months ago Evotec SE to Announce Q1 2025 Results on May 6 Financial Results Conference Call Evotec SE Therapeutics Development Webcast Details
Published on 08/19/2026 at 09:05, 1 hour 4 minutes ago BioNxt Advances Cladribine Clinical Program with Completion of the Investigational Medicinal Product Dossier (IMPD) Ahead of Human Clinical Studies
Published on 08/19/2026 at 07:00, 3 hours 9 minutes ago Caldwell Strengthens Life Sciences and Healthcare Practice with Addition of Olga Kozlova in Dubai
Published on 08/19/2026 at 04:00, 6 hours 9 minutes ago Momenta, XHEART, and QNX Build an Autonomous Driving Platform Certified to Global Safety Standards
Published on 08/18/2026 at 23:10, 10 hours 59 minutes ago Secure Blockchain Signs Agreement to Sell Delivery Trust(R) Business
Published on 08/18/2026 at 19:45, 14 hours 24 minutes ago ECC Ventures 5 Corp. Enters Into Business Combination Agreement with Bayrock Resources for Qualifying Transaction
Published on 08/19/2026 at 09:50, 19 minutes ago Narravero Named a Market Shaper in the 2026 Gartner® Emerging Market Quadrant for Digital Product Passport
Published on 08/19/2026 at 09:26, 43 minutes ago Correction of a release from 17/08/2026, 13:05 CET/CEST - Share buyback: Announcement pursuant to Article 5 (1) (b) and (3) of Regulation (EU) No. 596/2014
Published on 08/19/2026 at 09:23, 46 minutes ago aap Implantate AG: Appointment of new board members and change of CEO at aap Implantate AG
Published on 08/19/2026 at 09:19, 50 minutes ago EQS-Adhoc: aap Implantate AG: Changes in the Management Board
Published on 08/18/2026 at 18:00, 16 hours 9 minutes ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 16 hours 24 minutes ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 22 hours 54 minutes ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 22 hours 54 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 14 hours ago Aéroports de Paris S.A - July 2026 traffic figures
